Il-kodiċi HS/NM 30021010 huwa barra mill-kamp ta’ applikazzjoni għat-tħejjija għall-EUDR.
Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001) Il-magna indiċizzata tal-kamp ta’ applikazzjoni tagħti Out of scope għal dan il-kodiċi. No Annex I scope match was found for this indexed CN code.
Għaliex din il-paġna ta’ referenza tagħti dik it-tweġiba.
- Deskrizzjoni tal-kodiċi
- Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001)
- Bażi fl-Anness I
- L-ebda entrata diretta fl-Anness I
- Bażi tas-sors
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Ringieli ġenituri, subordinati u viċini.
Il-veduta tal-librerija hija għan-navigazzjoni ta’ referenza. Uża l-verifikatur meta trid tiċċekkja kodiċi ieħor bħala azzjoni.
30prodotti farmaċewtiċiout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Xi jfisser dan għat-tħejjija.
Din ir-ringiela mhijiex skattatur dirett għall-ġbir tal-evidenza fir-riżultat attwali tal-kamp ta’ applikazzjoni.
Regulation (EU) 2023/1115 Annex I — relevant productsmiksub fi 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115miksub fi 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)miksub fi 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)miksub fi 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8miksub fi 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingmiksub fi 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersmiksub fi 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)miksub fi 2026-08-08